EP1405636A4 — REGULATOR OF RECTINTOR FUNCTION RELATING TO RETINOIDS
Assigned to Takeda Pharmaceutical Co Ltd · Expires 2009-04-15 · 17y expired
What this patent protects
A function regulator for retinoid relative receptors (excluding retionic acid receptors) which contains a compound represented by the general formula (I) (wherein one of R1 and R2 represents an optionally substituted, monocyclic aromatic hydrocarbon group or an optionally substit…
USPTO Abstract
A function regulator for retinoid relative receptors (excluding retionic acid receptors) which contains a compound represented by the general formula (I) (wherein one of R1 and R2 represents an optionally substituted, monocyclic aromatic hydrocarbon group or an optionally substituted, monocyclic aromatic heterocyclic group containing one heteroatom and the other represents hydrogen, etc.; B represents a 5- or 6-membered heterocycle (excluding 1,3-azole); A represents an optionally substituted aromatic hydrocarbon group or an optionally substituted aromatic heterocyclic group; and R3 represents hydrogen, etc.) or a salt thereof. The regulator is useful as a preventive/remedy for diabetes, hyperlipidemia, impaired glucose tolerance, etc.
Drugs covered by this patent
- Trulance (PLECANATIDE) · Salix
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.